Nath Bio-Genes Reports H1FY27 Financial and Operational Results
Nath Bio-Genes (India) Ltd · Investor Presentation · 16 Nov 2026, 3:35 pm
Nath Bio-Genes Reports H1FY27 Financial and Operational Results For H1FY27, Nath Bio-Genes reported revenue of ₹3,601 Mn, up 13% YoY from ₹3,199 Mn, while gross profit rose 13% YoY to ₹1,922 Mn with margins flat at 53%. EBITDA fell 11% YoY to ₹410 Mn as margins compressed from 14% to 11%. PAT declined 18% YoY to ₹349 Mn due to a 50% increase in finance costs to ₹93 Mn. In Q2FY27, revenue dropped 6% YoY to ₹373 Mn, with PAT down 46% YoY to ₹23 Mn. Paddy (37%), cotton (26%), and bajra (13%) led H1 sales.
Original exchange filing (PDF)
More announcements from Nath Bio-Genes (India) Ltd
- Audio Transcript of Conference Call held on 16th November 2026 · 17 Nov 2026
- Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Unaudited Standalone and Consolidated Financial Results as on 30th September 2026 · 14 Nov 2026
- Intimation about Conference call to be held on 16th November 2026 at 04:00 PM · 16 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 14 Nov 2026
- NATH BIO-GENES (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 14 Nov 2026
- Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited financial .... · 14 Nov 2026
- Proceedings of AGM and Scrutinizers report for AGM held on 24th September 2026 · 24 Sept 2026
